Summary
Induction of hyperlipemia by high carbohydrate intake has been studied in 20 atherosclerotics. It appeared to be a fairly infrequent occurrence, being successful in only 25% of the patients studied. Induction was positive in 22% of the subjects with normal fasting lipid levels and in 60% of those with type IV hyperlipemia; it failed in the 6 patients with type II A or B hyperlipemia. Induction was not correlated to the degree of carbohydrate tolerance. Therefore, in patients with negative results of induction high triglyceride levels, as those found in types II B and IV, seem to be determined by genetic factors or by nutritional factors other than carbohydrates. Carbohydrate induction is quickly achieved, plasma triglycerides reaching their peak between days 3 and 5. Regression, too, starts early as a rule, sometimes even while the subject is still on the high carbohydrate diet. These findings are evidence of increased VLDL synthesis rather than reduced lipoprotein removal rate. Changes in the triglyceride/protein and triglyceride/cholesterol ratios are indicative of an increased size of both the VLDL and LDL fractions in the course of CHO-induced hyperlipemia.
Similar content being viewed by others
References
Ahrens E. H. Jr., Hirsch J., Oetta A., Farquhar J. W., Stein Y.: Carbohydrate-Induced and Fat-Induced Lipemia — Trans. Ass. Amer. Phycns74, 134, 1961.
Alaupovic P., Lee D. M., Gonatley W. J.: Studies on the Composition and Structure of Plasma Lipoproteins. Distribution of Lipoprotein Families in Major Density Classes of Normal Human Plasma Lipoproteins — Biochim. biophys. Acta (Amst.)260, 689, 1972.
Albrink M. J., Man E. B.: Serum Triglycerides in Coronary Artery Disease — Arch. intern. Med.103, 4, 1959.
Avogaro P., Capri C., Cazzolato G.: Tipizzazione lipidemica dell’aterosclerosi clinica — G. ital. Cardiol.2, 65, 1972.
Avogaro P., Crepaldi G., Enzi G., Tiengo A.: Association of Hyperlipemia, Diaberes Mellitus and Mild Obesity — Acta diabet. lat.4, 572, 1967.
Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T.: Classification of Hyperlipidaemias and Hyperlipoproteinaemias — Bull. Wld Hlth Org.43, 891, 1970.
Bierman E. L., Hamlin J. T. III: The Hyperlipemic Effect of a Low-Fat High-Carbohydrate Diet in Diabetic Subjects — Diabetes10, 432, 1961.
Bierman E. L., Porte D. Jr.: Carbohydrate Intolerance and Lipaemia — Ann. intern. Med.68, 926, 1968.
Blankenhorn D. H., Chin H. P., Lau F. Y.: Ischemic Heart Disease in Young Adults. Metabolic and Angiographic Diagnosis and Prevalence of Type IV Hyperlipoproteinemia — Ann. intern. Med.69, 21, 1968.
Brown D. F., Kinch S. H., Doyle J. T.: Serum Triglycerides in Health and in Ischemic Heart Disease — New Engl. J. Med.273, 947, 1965.
Carlson L. A.: Serum Lipids in Men with Myocardial Infarction — Acta med. scand.167, 399, 1960.
Eggstein M.: Eine neue Bestimmung der Neutralfette in Blutserum und Gewebe. II. Zuverlässigkeit der Methode, andere Neutralfettbestimmungen, Normalwerte für Triglyceride und Glycerin im menschlichen But — Klin. Wschr.44, 267, 1966.
Ewing A. M., Freeman N. K., Lindgren F. T.: The Analysis of Human Serum Lipoprotein Distributions — In:Paoletti R., Kritchevsky D. (Eds): Advances in Lipid Research. Vol. III. Academic Press, New York-London, 1965; p. 25.
Fiske C. H., Subbarow Y.: The Colorimetric Determination of Phosphorus — J. biol. Chem.66, 375, 1925.
Fredrickson D. S., Levy R. I., Lees R. S.: Fat Transport in Lipoproteins — an Integrated Approach to Mechanisms and Disorders — New Engl. J. Med.276, 34, 94, 148, 215 and 273, 1967.
Gertler M. M., Leetma H. E., Saluste E., Rosenberger J. L., Guthrie R. G.: Ischemic Heart Disease Insulin, Carbohydrate, and Lipid Interrelationships — Circulation46, 103, 1972.
Glueck C. J., Levy R. I., Fredrickson D. S.: Immunoreactive Insulin, Glucose Tolerance, and Carbohydrate Inducibility in Types II, III, IV, and V Hyperlipoproteinemia — Diabetes18, 739, 1969.
Havel R. J., Eder H. A., Bragdon J. H.: The Distribution and Chemical Composition of Ultracentrifugally Separated Lipoproteins in Human Serum — J. clin. Invest.34, 1345, 1955.
Heinle R. A., Levy R. I., Fredrickson D. S., Gorlin R.: Lipid and Carbohydrate Abnormalities in Patients with Angiographically Documented Coronary Artery Disease — Amer. J. Cardiol.24, 178, 1969.
Jones D. P., Losowsky M. S., Davidson C. S., Lieber C. S.: Effects of Ethanol on Plasma Lipids in Man — J. Lab. clin. Med.62, 675, 1963.
Kauffmann N. A., Poznanski R., Blondfieim S. H., Stein Y.: Changes in Serum Lipid Levels of Hyperlipemic Patients Following the Feeding of Starch, Sucrose and Glucose — Amer. J. clin. Nutr.18, 261, 1966.
Kuo P. T.: Current Metabolic-Genetic Interrelationship in Human Atherosclerosis with Therapeutic Considerations — Ann. intern. Med.68, 449, 1968.
Kuo P. T., Feng L. Y.: Study of Serum Insulin in Atherosclerotic Patients with Endogenous Hypertriglyceridemia (Types III and IV Hyperlipoproteinemia) — Metabolism19, 372, 1970.
Levine J., Morgenstern S., Vlastelica D.: A Direct Liebermann — Burchard Method for Serum Cholesterol — In: Automation in Analytical Chemistry. Technicon Symposia 1967. Mediad Inc., White Plains/N. Y., 1968; vol. I, p. 25.
Levy R. I., Lees R. S., Fredrickson D. S.: The Nature of Prebeta (Very Low-Density) Lipoproteins — J. clin. Invest.45, 63, 1966.
Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J.: Protein Measurement with the Folin Phenol Reagent — J. biol. Chem.193, 265, 1951.
Macdonald I.: Lipid Response to Dietary Carbohydrates — In:Paoletti R., Kritchevsky D. (Eds): Advances in Lipid Research. Vol. IV. Academic Press, New York-London, 1966; p. 39.
Mancini M., Mattoch M., Rabaya E., Chait A., Lewis B.: Studies of the Mechanism of Carbohydrate Induced Lipaemia in Normal Man — Atherosclerosis17, 445, 1973.
Nikkilä E. A., Ojala K.: Acute Effects of Fructose and Glucose on the Concentration and Removal Rate of Plasma Triglyceride — Life Sci.5, 89, 1966.
Reaven G. M., Lerner R. L., Stern M. P., Farquhar J. W.: Role of Insulin in Endogenous Hypertriglyceridemia — J. clin. Invest.46, 1756, 1967.
Ruderman N. B., Jones A. L., Krauss R. M., Shafrir E.: A Biochemical and Morphologic Study of Very Low Density Lipoproteins in Carbohydrate-Induced Hypertriglyceridemia — J. clin. Invest.50, 1355, 1971.
Sloan J. M., Mackay J. S., Sheridan B.: Glucose Tolerance and Insulin Response in Atherosclerosis — Brit. med. J.4, 586, 1970.
Tzagournis M., Chiles R., Ryan J. M., Skillman T. G.: Interrelationships of Hyperinsulinaemia and Hypertriglyceridaemia in Young Patients with Coronary Heart Disease — Circulation38, 1156, 1968.
Author information
Authors and Affiliations
Additional information
Servizio di Statistica, Ospedale Umberto I, Mestre.
Rights and permissions
About this article
Cite this article
Avogaro, P., Pais, M., Cazzolato, G. et al. Carbohydrate-induced hyperlipemia in human atherosclerosis. Acta diabet. lat 11, 479–485 (1974). https://doi.org/10.1007/BF02624587
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624587